PLC (NASDAQ: TCBP), a biotechnology firm with a market capitalization of $33.08 million engaged in developing gamma-delta T cell therapies, announced today significant progress in its ACHIEVE Phase 2B ...

Adding a new indication for the CAR T cell therapy could help BMS offset the loss-of-exclusivity headwinds it faces in the ...

MAH CET 2025: State Common Entrance Test Cell, Maharashtra will end the MAH CET 2025 registration process on Monday, February ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves the ability of immune cells to combat cancer for ...

About 5% of people who catch COVID have long-lasting symptoms. In these people, loss of smell, dizziness, fatigue and other ...

Three prisoners found hanging in their cells in the space of three weeks died in an "overwhelmed" jail, a jury has found. Anthony Binfield, Rolandas Karbauskas and David Richards were inmates at HMP ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to macrophage-based therapies, and clues behind why ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...